(Press-News.org)
Nanomedicines, especially those based on nanoparticles, are revolutionizing healthcare in terms of both diagnostics and therapeutics. These particles, often containing metals like iron or gold, can serve as contrast agents in medical imaging, act as nutritional supplements, and even function as carriers for drug delivery. Thanks to their unique properties plus careful engineering, nanomedicines can reach and accumulate in places within the body that conventional medicines cannot, making them promising for cancer detection and treatment. However, the same characteristics that make nanomedicines valuable also present challenges in ensuring their safety and quality.
Current pharmaceutical guidelines, including those from the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH), have a significant blind spot: they evaluate only the total amount of elements present in a medication without distinguishing between their different forms, such as ions or differently sized particles. This distinction is crucial because these different forms can have different effects on the body, including varying toxicity profiles.
Against this backdrop, a research team led by Assistant Professor Yu-ki Tanaka from the Graduate School of Pharmaceutical Sciences, Chiba University, Japan, has developed a new analytical method to address the existing regulatory gap. Their study, which was made available online in the journal Talanta on April 8, 2025, introduces a technique to separately quantify ions, nanoparticles, and aggregated particles in nanomedicines. Co-authored by Yasumitsu Ogra and Sana Hasegawa, also from Chiba University, the study showcases how this method can improve quality control for these advanced pharmaceutical products. “By incorporating a novel evaluation method that addresses a previously overlooked issue in current evaluation guidelines, we can ensure the safe use of metal-based nanomedicines such as Resovist® and Ferinject®” explains Dr. Tanaka.
The researchers combined two existing technologies—asymmetric flow field-flow fractionation (AF4) and inductively coupled plasma mass spectrometry (ICP-MS). They used the AF4 method in a novel way, taking advantage of its initial ‘focus step.’ During this step, particles are held inside the AF4 channel by two opposing flows. Using a special permeable membrane, cross-flows filter out the tiniest dissolved particles (ions), enabling quantification based on the differences in ICP-MS signals between samples with and without ion removal−namely, with and without the focus step. Once the ions are separated, the system then uses AF4’s standard separation process to sort the retained nanoparticles by size. Finally, the ICP-MS device attached to the output can determine the approximate number of nanoparticles of each size. This combination enabled the team to distinguish between free metal ions, small hydroxide colloids, and nanoparticles of various sizes, all containing the same metal element.
They tested their approach on Resovist®, a nanomedicine used as a contrast agent in liver magnetic resonance imaging scans. The analysis revealed that only 0.022% of the iron in Resovist® was present in ionic form. At approximately 6.3 micrograms per milliliter, this negligible amount falls well below levels of concern. Additionally, the team confirmed that the active nanoparticles were smaller than 30 nanometers in diameter, with some aggregates around 50 nanometers. Importantly, no large aggregates were detected, which could reduce the effectiveness of the contrast agent. These results confirm both the safety and stability of Resovist® as a nanomedicine.
The proposed technique is particularly relevant for emerging cancer treatments that use gold nanoparticles as drug delivery systems or metallic particles for photothermal therapy. These advanced treatments rely on the ‘enhanced permeability and retention (EPR) effect,’ by which nanoparticles leak from blood vessels around tumors and accumulate in cancerous tissue. “Since many novel nanomedicines consist of metal-based nanoparticles as their active ingredients, providing reliable methods for evaluating their safety and quality control will promote their development and clinical use,” notes Dr. Tanaka.
Additionally, this novel analytical approach extends beyond pharmaceuticals. It can also assess the safety of metal nanoparticles in food additives, cosmetics, and environmental samples—helping to ensure public health across multiple sectors. The researchers showcased its versatility by successfully analyzing both negatively charged ions (silicon) and positively charged ions (iron), indicating its potential for a wide range of nanomaterials.
Overall, by offering a more comprehensive assessment of the composition, quality, and stability of nanoparticles, this research paves the way for safer and more effective nanomedicines and nanoparticle-based technologies.
About Assistant Professor Yu-ki Tanaka
Yu-ki Tanaka is an Assistant Professor at the Graduate School of Pharmaceutical Sciences at Chiba University, Japan. He received his Doctor of Science degree from Kyoto University in 2017. His research interests include heavy metals, toxicity, single-cell/particle analysis, and isotopic composition analysis. He has over 30 publications to his name, with 1,900 reads and more than 300 citations. He is a member of notable academic societies, including the Pharmaceutical Society of Japan, the Japanese Society of Toxicology, and the Japan Society for Plasma Spectrochemistry.
END
Montreal, May 29, 2025 - Caffeine is not only found in coffee, but also in tea, chocolate, energy drinks and many soft drinks, making it one of the most widely consumed psychoactive substances in the world.
In a study published in April in Nature Communications Biology, a team of researchers from Université de Montréal shed new light on how caffeine can modify sleep and influence the brain's recovery — both physical and cognitive — overnight.
The research was led by Philipp Thölke, ...
CLEVELAND—CAR T cell immunotherapy, which uses a patient’s own modified immune cells to find and destroy cancer cells, can produce dramatic results when treating blood cancers like lymphoma and leukemia and shows promise against solid tumors.
But harvesting T cells, a type of white blood cell that helps the immune system fight germs and protect against disease, is difficult and expensive—limiting the use of this potentially life-saving therapy to major cancer centers and after other treatments have failed.
Now a team of researchers at Case Western Reserve University is developing a new device to harvest T cells that might make CAR ...
SHERBROOKE, Canada (May 29, 2025) – Nord Quantique, a pioneer in the field of quantum error correction, today announces a first in applied physics. The company has successfully developed bosonic qubit technology with multimode encoding, which outlines a path to a major reduction in the number of qubits required for quantum error correction (QEC). The result is an approach to quantum computing which will deliver smaller yet more powerful systems that consume a fraction of the energy. These smaller systems are also simpler to develop to utility-scale due to their size and lower requirements ...
Researchers have uncovered that some childhood cancers have a substantially higher number of DNA changes than previously thought, changing the way we view children’s tumours and possibly opening up new or repurposed treatment options.
Concentrating on a type of childhood kidney cancer, known as Wilms tumour, an international team genetically sequenced multiple tumours at a resolution that was previously not possible. This collaboration included researchers at the Wellcome Sanger Institute, University of Cambridge, Princess Máxima Center for Pediatric Oncology, the Oncode Institute in the Netherlands, Great Ormond Street Hospital, and Cambridge University ...
ITHACA, N.Y. – A new material developed at Cornell University could significantly improve the delivery and effectiveness of mRNA vaccines by replacing a commonly used ingredient that may trigger unwanted immune responses in some people.
Thanks to their ability to train cells to produce virus-killing proteins, mRNA vaccines have gained popularity over the last five years for their success in reducing the severity of COVID-19 infection. One method for delivering the mRNA to cells is by packaging it inside fatty spheres, called lipid nanoparticles, that protect it from being degraded. However, a common component of ...
The Atlantic meridional overturning circulation, commonly referred to as the “AMOC,” is a system of ocean currents confined to the Atlantic basin that plays a crucial role in regulating Earth’s climate by transporting heat from the Southern to the Northern Hemisphere. The AMOC also modulates regional weather, from the mild summers in Europe to the monsoon seasons in Africa and India. Climate models have long predicted that global warming will cause the AMOC to weaken, with some projecting substantial weakening ...
MISTRAL is a new generation receiver installed on the Sardinia Radio Telescope (SRT) and built by the Sapienza University of Rome for the National Institute for Astrophysics (INAF) as part of the upgrade of the radio telescope for the study of the Universe at high frequencies, funded by a PON (National Operational Program) project, concluded in 2023 and now providing its first significant scientific results. MISTRAL stands for “MIllimetric Sardinia radio Telescope Receiver based on Array of Lumped elements kids”.
MISTRAL is an innovative receiver in many ways. Radio astronomy ...
CHAMPAIGN, Ill. — In a review in The Philosophical Transactions of the Royal Society B, Stephen Long, a professor of crop sciences and of plant biology at the University of Illinois Urbana-Champaign, describes research efforts to “future-proof” the crops that are essential to feeding a hungry world in a changing climate. Long, who has spent decades studying the process of photosynthesis and finding ways to improve it, provides an overview of key scientific findings that offer a ray of hope.
Higher temperatures, more frequent and longer droughts, catastrophic rainfall events and rising atmospheric carbon dioxide levels all ...
LONDON, England
Revolutionary Platform Sets New Benchmark for Transparency and Compliance in Diagnostic AI
As the May 26th CE-IVDR compliance deadline comes into effect, Diagnostics.ai launches the industry’s first fully-transparent machine learning platform for clinical real-time PCR diagnostics – demonstrating exactly how each result was achieved, a first for molecular-testing machine learning. The technology is backed by over 15 years of experience and millions of successfully processed samples with >99.9% proven accuracy.
The CE-IVDR Strategic Advantage Platform is Diagnostics.ai's ...
The process of necrosis, a form of cell death, may represent one of the most promising ways to change the course of human aging, disease and even space travel, according to a new study from researchers at UCL, drug discovery company LinkGevity and the European Space Agency (ESA).
In the study, published in Nature Oncogene, a world-leading international team of scientists and clinicians explore the potential of necrosis – when cells die unexpectedly as a result of infection, injury or disease – to reshape our understanding and treatment of age-related conditions.
Challenging prevailing ...
